医学
低蛋白血症
肌酐
接种疫苗
肾病
膜性肾病
效价
透析
内科学
免疫学
胃肠病学
蛋白尿
抗体
内分泌学
肾
糖尿病
作者
Lorraine Gueguen,Charlotte Loheac,Nadia Saidani,L. Khatchatourian
标识
DOI:10.1016/j.kint.2021.08.006
摘要
A 76-year-old man with a history of hypertension and UV-treated cutaneous mycosis fungoid was vaccinated in January 2021 for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with Bnt162b2 and developed an antibody response. He had not had prior coronavirus disease 2019 (COVID-19) infection. He developed edema 4 days after vaccination with a random spot urine protein-to-creatinine ratio of 6.5 g/g, hypoalbuminemia (1.6 g/dl), hematuria, and normal serum creatinine (0.86 mg/dl). His anti–phospholipase A2 receptor autoantibody titer was found to be 1:800 (maximal dilution for this assay), supporting a diagnosis of membranous nephropathy (MN).
科研通智能强力驱动
Strongly Powered by AbleSci AI